Assignee
ALETHIA BIOTHERAPEUTICS INC
CA·10 granted patents·7 pending applications·51 citations·filing 2005–2023
Top patents by PatentIndex Score
17 records- 0195US7989160B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2007·Granted Aug 2, 2011·25 cites·34 claims
- 0288US9067984B2Methods of impairing osteoclast differentiation using antibodies that bind Siglec-15ALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 30, 2015·6 cites·13 claims
- 0387US8900579B2Siglec-15 antibodies in treating bone loss-related diseaseALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 2, 2014·8 cites·20 claims
- 0485US9393302B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·20 claims
- 0578US9388242B2Nucleic acids encoding anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·2 cites·20 claims
- 0676US9493562B2Anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 15, 2016·3 cites·14 claims
- 0775US9040246B2Methods of making antibodies that bind polypeptides involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted May 26, 2015·1 cites·9 claims
- 0874US7947436B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2005·Granted May 24, 2011·1 cites·31 claims
- 0969US2024317884A1Method for allowing immune cells infiltration in tumorsALETHIA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1064US2024199758A1Method for allowing immune cells infiltration in tumorsALETHIA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1162US9512211B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·0 cites·8 claims
- 1261US2024207311A1Tumor infiltrating lymphocytes therapyALETHIA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2025108110A1Combination therapy for use in treatment of non-small cell lung cancerALETHIA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1452US2017233487A1Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor VolumeALETHIA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1551US2016039930A1Polynucleotides and polypeptide sequences involved in cancerALETHIA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1649US2017174753A1Method for treating breast cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1747US9822170B2Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 21, 2017·0 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →